Literature DB >> 7527493

A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate.

J H Wasson1, D J Reda, R C Bruskewitz, J Elinson, A M Keller, W G Henderson.   

Abstract

BACKGROUND: Transurethral resection of the prostate is the most common surgical treatment for benign prostatic hyperplasia. We conducted a multicenter randomized trial to compare this surgery with watchful waiting in men with moderate symptoms of benign prostatic hyperplasia.
METHODS: Of 800 men over the age of 54 years who were screened between July 1986 and July 1989, 556 (mean [+/- SD] age, 66 +/- 5 years) were studied (280 in the surgery group and 276 in the watchful-waiting group). Patients' symptoms and the degree to which they were bothered by urinary difficulties were measured with standardized questionnaires and medical evaluations. The primary outcome measure was treatment failure, which was defined as the occurrence of any of the following: death, repeated or intractable urinary retention, a residual urinary volume over 350 ml, the development of bladder calculus, new and persistent incontinence, a high symptom score, or a doubling of the serum creatinine concentration. Patients were followed for three years.
RESULTS: Of the men randomly assigned to the surgery group, 249 underwent surgery within two weeks after the assignment. Surgery was not associated with impotence or urinary incontinence. The average follow-up period was 2.8 years. In an intention-to-treat analysis, there were 23 treatment failures in the surgery group, as compared with 47 in the watchful-waiting group (relative risk, 0.48; 95 percent confidence interval, 0.30 to 0.77). Of the men assigned to the watchful-waiting group, 65 (24 percent) underwent surgery within three years after the assignment. Surgery was associated with improvement in symptoms and in scores for urinary difficulties and interference with activities of daily living (P < 0.001 for all comparisons). The outcomes of surgery were best for the men who were most bothered by urinary symptoms at base line.
CONCLUSIONS: For men with moderate symptoms of benign prostatic hyperplasia, surgery is more effective than watchful waiting in reducing the rate of treatment failure and improving genitourinary symptoms. Watchful waiting is usually a safe alternative for men who are less bothered by urinary difficulty or who wish to delay surgery.

Entities:  

Mesh:

Year:  1995        PMID: 7527493     DOI: 10.1056/NEJM199501123320202

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  101 in total

1.  The competing effects of disease states on quality of life of the elderly: the case of urinary symptoms in men.

Authors:  B Mozes; Y Maor; A Shmueli
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

2.  Prostatic symptoms. Essential simple investigations were not mentioned.

Authors:  K Baxby
Journal:  BMJ       Date:  2001-09-29

Review 3.  Benign prostatic hyperplasia.

Authors:  M J Barry; C G Roehrborn
Journal:  BMJ       Date:  2001-11-03

Review 4.  Acute urinary retention in men: an age old problem.

Authors:  M Emberton; K Anson
Journal:  BMJ       Date:  1999-04-03

5.  TURP in the new century: an analytical reappraisal in light of lasers.

Authors:  Assaad El-Hakim
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

Review 6.  Chronic bacterial prostatitis and chronic pelvic pain syndrome.

Authors:  Diana K Bowen; Elodi Dielubanza; Anthony J Schaeffer
Journal:  BMJ Clin Evid       Date:  2015-08-27

7.  Self management for men with lower urinary tract symptoms: randomised controlled trial.

Authors:  Christian T Brown; Tet Yap; David A Cromwell; Lorna Rixon; Liz Steed; Kathleen Mulligan; Anthony Mundy; Stanton P Newman; Jan van der Meulen; Mark Emberton
Journal:  BMJ       Date:  2006-11-21

8.  Greenlight high-performance system (HPS) 120-W laser vaporization versus transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a meta-analysis of the published results of randomized controlled trials.

Authors:  Yan Zhou; Boxin Xue; Nadeem Ahmed Mohammad; Dong Chen; Xiaofei Sun; Jinhui Yang; Guangcheng Dai
Journal:  Lasers Med Sci       Date:  2016-02-11       Impact factor: 3.161

Review 9.  The rationale for a spine registry.

Authors:  C Röder; U Müller; M Aebi
Journal:  Eur Spine J       Date:  2005-11-16       Impact factor: 3.134

Review 10.  Predictive medicine in non-malignant urological disorders.

Authors:  Mariangela Mancini; Antonio Cisternino; Ivan Matteo Tavolini; Fabrizio Dal Moro; Pierfrancesco Bassi
Journal:  World J Urol       Date:  2003-12-20       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.